EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)
$0.615 0.015 (2.5%)
Analysed EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) News Sources
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
18-08-2025
yahoo.com
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
28-08-2025
yahoo.com
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
17-09-2025
yahoo.com
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
06-10-2025
yahoo.com
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
15-10-2025
yahoo.com
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
21-10-2025
yahoo.com
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
30-10-2025
yahoo.com
Eagle Pharmaceuticals Announces Divestiture of Barhemsys
14-01-2026
yahoo.com
What is the current price of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)?
The current price of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) is $0.615.
EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) absolute price change since previous trading day?
The absolute price change of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) since the previous trading day is $0.015.
EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) percentage price change since previous trading day?
The percentage price change of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) since the previous trading day is 2.5%.
What is the most recent average sentiment score for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)?
The most recent average sentiment score for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) is 68 out of 100.
What is the most recent average sentiment for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)?
The most recent sentiment for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) is .
SEC-8K** Filing Available For EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.